Year |
Citation |
Score |
2023 |
Smith PT, Ye Z, Pietryga J, Huang J, Wahl CB, Hedlund Orbeck JK, Mirkin CA. Molecular Thin Films Enable the Synthesis and Screening of Nanoparticle Megalibraries Containing Millions of Catalysts. Journal of the American Chemical Society. 145: 14031-14043. PMID 37311072 DOI: 10.1021/jacs.3c03910 |
0.317 |
|
2017 |
Chen W, Huang Z, Wang W, Mao F, Guan L, Tang Y, Jiang H, Li J, Huang J, Jiang L, Zhu J. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. Bioorganic & Medicinal Chemistry. PMID 29111368 DOI: 10.1016/j.bmc.2017.10.017 |
0.334 |
|
2016 |
Lang L, Dong N, Wu D, Yao X, Lu W, Zhang C, Ouyang P, Zhu J, Tang Y, Wang W, Li J, Huang J. 2-Arylbenzo[b]furan derivatives as potent human lipoxygenase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 1-8. PMID 27590167 DOI: 10.1080/14756366.2016.1220376 |
0.349 |
|
2016 |
Xiao Q, Dong N, Yao X, Wu D, Lu Y, Mao F, Zhu J, Li J, Huang J, Chen A, Huang L, Wang X, Yang G, He G, Xu Y, et al. Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H. Scientific Reports. 6: 25298. PMID 27126280 DOI: 10.1038/srep25298 |
0.311 |
|
2015 |
Yan W, Qing J, Mei H, Nong J, Huang J, Zhu J, Jiang H, Liu L, Zhang L, Li J. Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition. Bioorganic & Medicinal Chemistry Letters. PMID 26564266 DOI: 10.1016/J.Bmcl.2015.11.002 |
0.362 |
|
2015 |
Yan W, Qing J, Mei H, Mao F, Huang J, Zhu J, Jiang H, Liu L, Zhang L, Li J. Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization. Molecules (Basel, Switzerland). 20: 10342-59. PMID 26053489 DOI: 10.3390/Molecules200610342 |
0.324 |
|
2012 |
Lv M, Shi T, Mao X, Li X, Chen Y, Zhu J, Ni S, Shen X, Jiang H, Li J, Zhang J, Huang J. 1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: a novel cyclophilin A allosteric activator. Biochemical and Biophysical Research Communications. 425: 938-43. PMID 22906739 DOI: 10.1016/J.Bbrc.2012.08.014 |
0.375 |
|
2012 |
Wu D, Jin F, Lu W, Zhu J, Li C, Wang W, Tang Y, Jiang H, Huang J, Liu G, Li J. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Chemical Biology & Drug Design. 79: 897-906. PMID 22381062 DOI: 10.1111/j.1747-0285.2012.01365.x |
0.368 |
|
2012 |
Huang H, Lu W, Li X, Cong X, Ma H, Liu X, Zhang Y, Che P, Ma R, Li H, Shen X, Jiang H, Huang J, Zhu J. Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent. Bioorganic & Medicinal Chemistry Letters. 22: 958-62. PMID 22192590 DOI: 10.1016/j.bmcl.2011.12.011 |
0.36 |
|
2011 |
Lu W, Che P, Zhang Y, Li H, Zou S, Zhu J, Deng J, Shen X, Jiang H, Li J, Huang J. HL005--a new selective PPARγ antagonist specifically inhibits the proliferation of MCF-7. The Journal of Steroid Biochemistry and Molecular Biology. 124: 112-20. PMID 21296151 DOI: 10.1016/j.jsbmb.2011.01.019 |
0.357 |
|
2009 |
Ni S, Yuan Y, Huang J, Mao X, Lv M, Zhu J, Shen X, Pei J, Lai L, Jiang H, Li J. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach. Journal of Medicinal Chemistry. 52: 5295-8. PMID 19691347 DOI: 10.1021/Jm9008295 |
0.328 |
|
2009 |
Li H, Huang J, Chen L, Liu X, Chen T, Zhu J, Lu W, Shen X, Li J, Hilgenfeld R, Jiang H. Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening. Journal of Medicinal Chemistry. 52: 4936-40. PMID 19586036 DOI: 10.1021/jm801622x |
0.35 |
|
2009 |
Zhu J, Chen T, Liu J, Ma R, Lu W, Huang J, Li H, Li J, Jiang H. 2-(3,4-dihydro-4-oxothieno[2,3-d]pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. design, synthesis and biological evaluation. Molecules (Basel, Switzerland). 14: 785-97. PMID 19223827 DOI: 10.3390/molecules14020785 |
0.376 |
|
2009 |
Zhu J, Chen T, Chen L, Lu W, Che P, Huang J, Li H, Li J, Jiang H. 2-Amido-3-(1H-Indol-3-yl)-N-substitued-propanamides as a new class of falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies Molecules. 14: 494-508. PMID 19158658 DOI: 10.3390/molecules14010494 |
0.368 |
|
Show low-probability matches. |